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Introduction {#sec1}
============

The complex organization of the adult body arises during development by formation of distinct tissues at different locations, many of which are then further subdivided into domains with a specific regional identity. Such regionalization occurs along the anterior-posterior (A-P) axis of the vertebrate central nervous system to form subdivisions that are demarcated by sharp borders. A-P patterning of the neural epithelium is achieved through graded cell signaling, mediated by retinoic acid (RA) and members of the Fgf and Wnt families ([@bib67]), which regulates the spatial expression of transcription factors that specify regional identity ([@bib44], [@bib68]). However, at early stages the borders between different subdivisions are ragged and there can be overlapping expression of transcription factors that confer different identities. This imprecision is likely due in part to variability in the formation and interpretation of gradients of signals. In addition, the proliferation and intercalation of cells during tissue growth and morphogenesis can potentially scramble the pattern by causing intermingling of cells between adjacent regions. This raises the questions of how, despite these challenges, a sharp border forms at the interface of subdivisions, and each subdivision acquires a homogeneous regional identity. Insights into underlying mechanisms have come from studies of the vertebrate hindbrain.

The hindbrain is subdivided into seven segments, termed rhombomeres (r1--r7), which underlie the organization and A-P specification of neurons and branchial neural crest cells ([@bib35]). Regionalization of the hindbrain is established by graded Fgf and RA signaling, which regulates the spatial expression of a network of transcription factors that underlie the formation and A-P identity of hindbrain segments, including Egr2 (Krox20), MafB, and Hox family members ([@bib68]). Initially, there is some overlap at borders between *hoxb1* expression in r4, and *egr2* expression in r3 and r5, which is resolved bdevcel_4183_gr4_4c.eps - y mutual repression such that cells express one or the other transcription factor ([@bib19], [@bib31], [@bib78]). The borders of *egr2* expression in r3 and r5 are ragged when first detected, and then progressively become sharp and straight ([@bib13], [@bib24], [@bib25]). This sharpening is driven by signaling between segmentally expressed Eph receptors and ephrins that segregates cells and prevents intermingling across borders ([@bib11], [@bib12], [@bib25], [@bib75], [@bib77]), potentially through regulation of cell adhesion, tension, and/or repulsion ([@bib7], [@bib8], [@bib16], [@bib63]). Computer simulations suggest that cell segregation and the resolution of cell identity have synergistic roles in border sharpening ([@bib70]).

A further mechanism required to establish segments with homogeneous identity was suggested by the results of clonal analyses in the chick hindbrain. Once rhombomeres are seen at the morphological level, intermingling of cells is restricted across segment borders, but the progeny of individual cells labeled at earlier stages can contribute to adjacent segments ([@bib17]). The finding that some intermingling occurs between hindbrain segments implies that cells that move into another segment acquire an identity in accordance with their new A-P location. Direct evidence for an ability of hindbrain cells to switch A-P identity has come from transplantation experiments in mouse and zebrafish embryos. It was found that when single cells are transplanted between hindbrain segments, they downregulate markers of their site of origin and switch to the identity of their new location ([@bib25], [@bib51], [@bib66]). In zebrafish, cells can switch identity at early stages of segmentation (11.5 hr post fertilization \[hpf\]), but this plasticity progressively decreases at later stages (14--16.5 hpf) ([@bib51]). In contrast to single cells, groups of cells transplanted between segments maintain their original identity, suggestive of a community regulation of cell identity ([@bib51], [@bib66]). Such community effects have been found in other contexts to be mediated by positive feedback between transcription factors and intercellular signals that regulate cell identity ([@bib3], [@bib6], [@bib14], [@bib21], [@bib61]). Through non-autonomous induction of transcription factor expression, this feedback promotes a homogeneous identity within a field of cells ([@bib3]). Interestingly, mosaic overexpression of *egr2* in the chick hindbrain induces *egr2* expression in neighboring cells ([@bib19]), but the molecular basis of this non-autonomous induction is not known.

The findings from transplantation experiments have led to the idea that cell identity switching could act in parallel with cell segregation to establish sharp and homogeneous segments ([@bib13], [@bib46]). However, it is unclear to what extent intermingling of cells between segments occurs during normal development. *egr2* has a key role in hindbrain segmentation through specification of r3 and r5 identity ([@bib54], [@bib69]) and is a direct transcriptional regulator of *ephA4* ([@bib65]), which underlies cell segregation ([@bib12], [@bib75], [@bib77]). It is therefore likely that intermingling between segments is confined to the time period before there has been sufficient upregulation of EphA4 to drive cell segregation. Consistent with findings in chick ([@bib17]), some isolated cells expressing *egr2* or *egr2*-cre reporter are detected in even-numbered segments in the mouse hindbrain ([@bib24], [@bib69]). However, recent work has suggested that there is no intermingling between hindbrain segments in zebrafish, and therefore cell identity switching does not occur ([@bib7]). In this study, tracking of cells in time-lapse movies from 11 hpf did not detect intermingling between segments, and fluorescent reporter expression driven downstream of *egr2* was not detected in any cells in adjacent segments ([@bib7]). However, interpretation of these findings may be limited by timing of the analyses, as mechanisms that restrict cell intermingling may already be in place by 11 hpf and prior to detectable expression of the transgenic reporters.

We set out to analyze the role and mechanisms of cell identity switching in establishment of homogeneous segmental identity. By using genome modification to create an early reporter of *egr2* expression, we show that cell intermingling and identity switching occurs during hindbrain segmentation in zebrafish. *egr2* expression is regulated by a combination of A-P location and non-autonomous mechanisms that depend upon the number of neighbors that express *egr2*. We uncover a crucial role of RA-degrading enzymes, *cyp26b1* and *cyp26c1*, which we show are regulated by *egr2* and are required for identity switching of r3 and r5 cells that intermingle into adjacent segments. These findings reveal that coupling between segment identity and retinoid signaling enables homogeneous segmental identity to be maintained despite intermingling of cells.

Results {#sec2}
=======

Cell Intermingling and Identity Switching Occurs in the Zebrafish Hindbrain {#sec2.1}
---------------------------------------------------------------------------

In zebrafish, *egr2* is upregulated in prospective r3 and then r5, starting at 10--11 hpf respectively, and the initially ragged borders of *egr2* gene expression are sharpened over a 2 hr period ([@bib13], [@bib25], [@bib78]). Some ectopic *egr2*-expressing cells are detected in even-numbered segments, which potentially could segregate back to r3 or r5 or switch identity. To create an early-expressed reporter of cells with r3 or r5 identity, we used an enhancer trap strategy in which *H2B-Citrine* with a minimal promoter was inserted upstream of the *egr2b* gene by CRISPR/Cas9-mediated recombination ([Figure 1](#fig1){ref-type="fig"}A). This was found to drive reporter expression in r3 and r5. To maximize reporter expression, we created a line homozygous for *egr2b:H2B-Citrine*. *In situ* hybridization reveals that *citrine* and *egr2b* transcripts are concurrently expressed in r3 and r5 from the earliest time that *egr2b* expression is detected ([Figures 1](#fig1){ref-type="fig"}B--1O). Importantly, this analysis reveals that insertion of the reporter gene has not blocked expression of *egr2b*. Comparison of time-lapse movies with *in situ* hybridization data reveals that citrine fluorescence is first seen ∼1 hr after detection of *egr2* transcripts.Figure 1Generation of *egr2b* Gene Trap Expressing H2B-Citrine(A) CRISPR-mediated insertion of a donor construct with *cFos* minimal promoter and H2B-Citrine upstream of the transcriptional start site of *egr2b* to generate the Tg\[*egr2b:H2B-Citrine*\] line.(B--O) *In situ* hybridization to detect *egr2b* (B--H) and *citrine* (I--O) transcripts in Tg\[*egr2b:H2B-Citrine*\] embryos from 10 to 15 hpf. Embryos are flat-mounted with anterior to the left.(P--S) Selected frames from a time-lapse movie of a Tg\[*egr2b:H2B-Citrine*\] embryo acquired from 12 hpf (t = 0 min) for 280 min. A higher resolution image was captured at the final time point (S). Below each panel is a magnified view of the indicated areas (i, ii), with arrowheads pointing at three examples of H2B-Citrine-expressing cells that are ectopic at the final time point. When first detected, these cells are already surrounded by non-expressing cells. Most of the H2B-Citrine-expressing cells seen posterior to r5 are *egr2*-expressing neural crest cells. Scale bars: 50 μm.

Due to the high stability of H2B fusions with fluorescent reporters ([@bib5], [@bib42]), H2B-Citrine will perdure in any cells that have intermingled and downregulated *egr2b* transcripts. Analysis of time-lapse movies reveals the presence of some isolated cells with Citrine fluorescence within even-numbered segments, which have not segregated back to r3 or r5 by 16 hpf ([Figure 1](#fig1){ref-type="fig"}). When these cells are back-tracked, they are found to already be surrounded by non-expressing cells at the earliest time point at which Citrine fluorescence can be detected ([Figures 1](#fig1){ref-type="fig"}P--1S). This suggests that intermingling into adjacent segments occurs at early stages, during convergent-extension movements in which there is extensive intercalation of cells ([@bib28]). Since *egr2* expression is being upregulated during this period of convergent extension ([Figures 1](#fig1){ref-type="fig"}B--1E), the 1 hr delay in accumulating sufficient Citrine protein for direct detection may limit the ability to detect cells that have intermingled and then downregulated *egr2b* transcripts, which have a half-life of ∼30 min ([@bib4]).

Based on these findings, we increased sensitivity of detection by immunostaining for Citrine protein, and found that at 17 hpf there are 2--6 isolated Citrine-expressing cells per even-numbered segment ([Figures 2](#fig2){ref-type="fig"}A and 2C). As predicted from previous studies, knockdown of EphA4 increases cell intermingling between segments, with 8--13 cells expressing Citrine reporter per even-numbered segment ([Figures 2](#fig2){ref-type="fig"}B and 2C). To determine whether ectopic Citrine-expressing cells have maintained or changed identity, we carried out *in situ* hybridization for *egr2b* and *hoxb1a* transcripts. We found that Citrine-expressing cells in even-numbered segments do not express *egr2b*, and when present in r4 express *hoxb1a*, and have therefore switched to r4 identity ([Figure 2](#fig2){ref-type="fig"}D).Figure 2Cell Identity Switching of Ectopic *egr2:H2B-Citrine*-Expressing Cells(A and B) Maximum intensity projections of typical uninjected (A) and *ephA4* morphant (B) Tg\[*egr2b:H2B-Citrine*\] embryos at 17 hpf, with H2B-Citrine protein detected using anti-GFP antibody. Lateral views of the same embryos are shown in (A′) and (B′). Examples of Citrine-positive cells outside r3 and r5 are indicated by arrowheads.(C) Quantification of isolated ectopic Citrine-positive cells in uninjected and *ephA4* morphant embryos. Mean numbers with 95% confidence intervals are shown. Asterisks indicate statistical significance determined by Welsh\'s t test: r2, p = 0.0014; r4, p = 0.0017; r6, p = 0.0016; total isolated ectopic cells in r2, r4, and r6, p = 0.0002. n = 18 embryos (uninjected), n = 11 embryos (*ephA4* morphants).(D) Double *in situ* hybridization reveals that isolated Citrine-expressing cells (green in D‴, arrowheads in D, D″) in r2, r4, and r6 of *ephA4* morphant Tg\[*egr2b:H2B-Citrine*\] embryos have downregulated *egr2b* transcripts (blue in D, grayscale in D′; 105/121 cells). Citrine-expressing cells located in r4 have upregulated *hoxb1a* (magenta in D, scale in D″). Single slices from a confocal z stack are shown. Scale bars: 50 μm.

Cell Organization Influences Non-autonomous Induction of *egr2b* Expression {#sec2.2}
---------------------------------------------------------------------------

Our findings reveal that at early stages there is some intermingling of cells expressing *egr2b* into adjacent segments, and these ectopic cells switch identity. This raises the question of how cell identity switching is regulated. Since the initial pattern of segmental identities is established by graded signaling ([@bib22], [@bib73], [@bib74]), one potential mechanism for switching is that cells respond to the amount of signal present at their new location. However, this model does not explain why groups of transplanted cells do not switch identity ([@bib51], [@bib66]). Experiments in chick embryos suggest that *egr2* could be a component of a community regulation of cell identity since forced mosaic expression of *egr2* in r2, r4, and r6 induces *egr2* expression in adjacent cells ([@bib19]). We therefore analyzed whether *egr2* expression is influenced by interactions with neighboring cells.

We first tested whether non-autonomous induction of *egr2* expression occurs in the zebrafish hindbrain. To achieve sustained expression of myc-tagged Egr2b, we used a *pax3* regulatory element (CNE1) that drives gene expression in the dorsal neural epithelium ([@bib41]). Injection of this construct into zebrafish embryos led to mosaic ectopic expression of *egr2b*. We found that, at 12.5 hpf, cells ectopically expressing *egr2b* are scattered, and that endogenous *egr2b* is upregulated in adjacent cells in r2, r4, and r6 ([Figure 3](#fig3){ref-type="fig"}A). In contrast, by 17 hpf the *egr2b*-overexpressing cells have segregated to the borders of even-numbered segments, and non-autonomous induction of *egr2b* no longer occurs ([Figure 3](#fig3){ref-type="fig"}B). One potential explanation for this lack of non-autonomous induction is that it is influenced by the proportion of neighboring cells that express *egr2b*. Another possibility is that cells no longer respond to signaling from *egr2*-expressing cells as they have reduced plasticity at the later stage ([@bib51]). Since segregation of *egr2b*-expressing cells is mediated by EphA4 ([@bib12], [@bib65], [@bib75]), they can be maintained in a dispersed state by simultaneous knockdown of *ephA4*. We found that, in this situation, non-autonomous induction of *egr2b* occurs at 17 hpf ([Figure 3](#fig3){ref-type="fig"}C).Figure 3Relationship between Cell Organization and Non-autonomous Induction of *egr2* Gene Expression(A--C) Embryos injected with *CNE1:egr2b-Myc* and fixed at various time points to detect endogenous *egr2b* transcripts. At 12 hpf (A), endogenous *egr2b* gene expression (magenta) is upregulated in cells overexpressing Egr2b-Myc (green nuclei) and non-autonomous upregulation of *egr2b* is also observed in adjacent cells (hollow arrowheads, Ai and Aii). DAPI staining (grayscale) is shown in (Ai′) and (Aii′). By 17 hpf (B), Egr2b-Myc-expressing cells become segregated to the borders of r3 and r5, and non-autonomous upregulation of *egr2b* is no longer observed in adjacent cells (Bi and Bii, solid arrowheads). Knockdown of *ephA4* (see also [Figure S1](#mmc1){ref-type="supplementary-material"}) in embryos injected with *CNE1:egr2b-Myc* (C) causes cells overexpressing Egr2b-Myc to remain dispersed throughout the neuroepithelium at 17 hpf and non-autonomous upregulation of *egr2b* is now observed (Ci and Cii, hollow arrowheads).(D--H) Transient expression of *egr2b* by heat shock of Tg\[*hsp70:egr2b-Myc*\] embryos (*hs-egr2b*) at 11.3 hpf induces upregulation of endogenous *egr2b* in r2, r4, and r6 (E); compare with control embryo shown in (D). H2B-GFP labeled wild-type donor cells were transplanted into *hs-egr2b* embryos at 4 hpf, which were heat shocked at 11.3 hpf to induce widespread expression of *egr2b* (F). Wild-type donor cells in r2 upregulate endogenous *egr2b* non-autonomously when isolated or dispersed (G, H, hollow arrowheads) but not when clustered together, indicated by the region encircled by white dashed line in (H). White dashed lines in (E), (G), and (H) indicate presumptive rhombomere borders. Single slices from a confocal z stack are shown. Scale bars: 50 μm.

To further test the relationship between cell organization and non-autonomous *egr2* induction, we created embryos that have mosaic ectopic expression of the endogenous *egr2* gene. We took advantage of the finding that *egr2* gene regulation involves an autoregulatory element that maintains expression following an initial pulse of *egr2* expression ([@bib4], [@bib10]). We established a transgenic line with heat-shock-regulated *egr2b* (*hs-egr2b*) and used this to induce an early pulse of *egr2b* expression, which leads to ectopic expression of endogenous *egr2b* in even-numbered segments ([Figures 3](#fig3){ref-type="fig"}D and 3E) ([@bib4], [@bib10]). We transplanted labeled wild-type cells into the *hs-egr2* line, induced *egr2b* expression, and analyzed whether there is non-autonomous induction of *egr2* expression in wild-type cells present in even-numbered segments ([Figure 3](#fig3){ref-type="fig"}F). We found that wild-type cells express *egr2b* if intermingled with *hs-egr2b* cells ([Figure 3](#fig3){ref-type="fig"}G), but groups of wild-type cells do not upregulate *egr2b* ([Figure 3](#fig3){ref-type="fig"}H). Taken together, these findings suggest that non-autonomous induction of *egr2b* expression in even-numbered segments depends upon having a sufficient number of neighbors that are expressing *egr2b*.

In view of these findings, we wondered whether cells downregulate *egr2b* expression when surrounded by non-expressing cells, as occurs when they intermingle into adjacent segments. Since autoregulation is required to sustain expression, knockdown of *egr2b* leads to loss of *egr2b* expression in r3 and to a lesser extent in r5 by 17 hpf, leading to depletion of r3 and r5 territory, whereas markers of r2 and r4 identity are still expressed ([Figure S2](#mmc1){ref-type="supplementary-material"}) ([@bib4], [@bib10]). By transplanting wild-type cells into *egr2b* morphant embryos ([Figure 4](#fig4){ref-type="fig"}A), we created embryos in which only some cells are competent to maintain *egr2b* expression. We found that even small groups of wild-type cells present at the border of r2 and r4 are able to express *egr2b* (r3^∗^ in [Figure 4](#fig4){ref-type="fig"}B). As a further test, we prevented clustering of *egr2*-expressing cells by carrying out analogous experiments with *ephA4* morphant cells transplanted into *egr2* morphant embryos ([Figure 4](#fig4){ref-type="fig"}C). We found that *egr2b*-expressing cells were still present, even when organized as single cells at the border of r2 and r4 ([Figure 4](#fig4){ref-type="fig"}D). Thus, *egr2b* expression can be maintained in cells at the normal A-P location of r3 when surrounded by cells which are not expressing *egr2b*. This suggests that A-P patterning of cell identity is dominant over community signaling.Figure 4Effect of Decreasing the Number of *egr2b*-Expressing Cells(A and B) H2B-GFP-labeled wild-type donor cells were transplanted into *egr2a* plus *egr2b* morphant hosts (A). Since autoregulation is required to maintain *egr2* expression ([Figure S2](#mmc1){ref-type="supplementary-material"}), only the transplanted cells can express *egr2* in r3 at this stage. Wild-type donor cells at the position of r3 (denoted r3^∗^) in *egr2* morphants form a small cluster and maintain *egr2b* expression at 17 hpf (B, white arrowhead).(C and D) H2B-GFP-labeled *ephA4* morphant donor cells were transplanted into *egr2* morphant hosts (C). *ephA4* morphant donor cells no longer cluster in r3^∗^ but still maintain *egr2b* expression (D, white arrowheads). Single slices from a confocal z stack are shown. Scale bars: 50 μm.

Egr2b Regulates the Segmental Expression Level of *cyp26b1* and *cyp26c1* {#sec2.3}
-------------------------------------------------------------------------

Our findings raise the question of how *egr2* expression can occur in single cells at the correct A-P location but is downregulated in isolated cells present in even-numbered segments, whereas groups of cells can maintain segmental identity in an ectopic location. Previous studies have shown that a high posterior to low anterior gradient of RA has a key role in establishing segmental identity in the hindbrain ([@bib68], [@bib74]). A gradient of RA is created by a counter-gradient of the RA-degrading enzyme, *cyp26a1*, which is regulated by RA and Fgf signaling ([@bib73]). Two other family members, *cyp26b1* and *cyp26c1*, are expressed in dynamic segmental patterns in the hindbrain, and unlike *cyp26a1* are not direct targets of RA signaling ([@bib20], [@bib22], [@bib59], [@bib79]). This dynamic regulation of *cyp26b1* and *cyp26c1* expression may also establish a gradient of RA that underlies A-P patterning ([@bib22], [@bib59]). Since knockdown of *cyp26b1* or *cyp26c1* only leads to changes in segment identity when combined with loss of *cyp26a1* function ([@bib22]), these *cyp26* family members have overlapping roles in regulating RA levels. We speculated that *cyp26b1* and *cyp26c1* may have a further role in which they are regulated by segment identity genes, and act in a homeostatic feedback mechanism that maintains an RA level appropriate for the A-P position. Furthermore, by acting as a sink for RA, Cyp26 enzymes can have non-autonomous effects by influencing RA levels in adjacent cells ([@bib49], [@bib50], [@bib73]). We therefore wondered whether there is feedback between *egr2* and *cyp26* genes that contributes to regulation of the segmental identity of cells.

To test this idea, we carried out loss and gain of function experiments to determine whether *cyp26b1* and *cyp26c1* expression is regulated by *egr2*. *cyp26b1* is expressed in r2-r4, at lower levels in r2 and r3 than in r4 ([Figures 5](#fig5){ref-type="fig"}A and 5E), and *cyp26c1* is expressed in r2, r4, and r6, with lower expression in r3 and r5 ([Figures 5](#fig5){ref-type="fig"}C and 5G). Thus collectively, *cyp26b1* and *cyp26c1* are expressed at lower levels in r3 and r5 than in r2, r4, and r6. We found that, following *egr2* knockdown, *cyp26b1* expression in r3 increases to the same level as in r4 ([Figures 5](#fig5){ref-type="fig"}B and 5F), and *cyp26c1* expression increases in r3 and r5 ([Figures 5](#fig5){ref-type="fig"}D and 5H). In gain of function experiments, we induced an early pulse of *egr2b* expression using the *hs-egr2b* transgenic line, such that endogenous *egr2b* is upregulated throughout the hindbrain ([Figure 3](#fig3){ref-type="fig"}E). We found that, in this situation, *cyp26b1* and *cyp26c1* expression is lower in r4, and now at the same level as in r3, and that *cyp26c1* expression also decreases in r2 and r6 ([Figures 5](#fig5){ref-type="fig"}I--5P). The results of these loss and gain of function experiments reveal that *egr2b* underlies the lower level of *cyp26b1* and *cyp26c1* expression in r3 and r5 compared with r2, r4, and r6.Figure 5Relationships between *egr2*, *cyp26b1*, *cyp26c1*, and RA Signaling(A--H) Effect of *egr2a* plus *egr2b* knockdown (*egr2* morpholino oligonucleotides \[MO\]) on *cyp26b1* and *cyp26c1* expression. *egr2* knockdown increases the level of *cyp26b1* expression in r3 (black arrowhead) at 13 hpf (B) and 15 hpf (F), and of *cyp26c1* in r3 and r5 (black arrowheads) at 13 hpf (D) and 15 hpf (H) compared with control embryos (A, C, E and G). r3^∗^ and r5^∗^ in (B), (D), (F), and (H) refer to the region specified as r3 or r5 in the presence of *egr2*.(I--P) Expression of *cyp26b1* and *cyp26c1* in control embryos and after induction of widespread *egr2* expression by heat shock of *hs-egr2b* embryos at 11.3 hpf. Widespread expression of *egr2b* leads to reduction of *cyp26b1* expression in r4 (black arrowhead) at 13 hpf (J), and 15 hpf (N) compared with control embryos (I and M). Similarly, *cyp26c1* expression is reduced in r2, r4, and, to a lesser extent, in r6 (black arrowheads) at 13 hpf (L) and 15 hpf (P) in comparison with control embryos (K and O).(Q--T) *hs-egr2b* embryos subjected to heat shock at 11.3 hpf in the presence (S and T) or absence (Q and R) of the pan-RAR antagonist AGN193109. Endogenous *egr2b* expression was analyzed at 16.5 hpf. In DMSO-treated control embryos, endogenous *egr2b* is expressed in r2, r4, and r6, but to a lesser extent in ventral r4 (Q and R). In AGN193109-treated embryos, expression of endogenous *egr2b* in r2, r4, and r6 is more heterogeneous and there are patches of cells that do not express endogenous *egr2b* (black arrowheads in S and T).Embryos in (A)--(P) are flat-mounted with anterior to the top; embryos in (Q) and (S) are flat-mounted with anterior to the left; embryos in (R) and (T) are side-mounted with anterior to the left. Dashed lines in (Q)--(T) indicate presumptive rhombomere borders. Scale bars: 50 μm.

Feedback Occurs between *egr2b* Expression and RA Signaling {#sec2.4}
-----------------------------------------------------------

The above findings suggest a model in which the repression of *cyp26b1* and *cyp26c1* expression by *egr2* leads to an increased level of RA, which in turn enables maintenance of *egr2* expression. To test this, we analyzed whether RA signaling contributes to the regulation of endogenous *egr2b* expression in r2, r4, and r6 that is induced by a pulse of *hs-egr2b* expression. In control embryos, this leads to sustained *egr2* expression throughout the hindbrain due to transcriptional autoregulation of the *egr2* gene ([@bib4], [@bib10]), which at 16.5 hpf is uniform, except for low levels in ventral r4 ([Figures 5](#fig5){ref-type="fig"}Q and 5R). We used a chemical blocker to inhibit retinoic acid receptor (RAR) following the pulse of *egr2* expression and found that this does not alter expression in r3 or r5, but has a striking effect in even-numbered segments at 16.5 hpf. We found that there is lower expression of *egr2b* in even-numbered segments compared with controls, with the strongest decrease in r4 ([Figures 5](#fig5){ref-type="fig"}S and 5T). Interestingly, following RAR inhibition, the level of *egr2b* expression is no longer homogeneous in r2, r4, and r6, and is organized in stripes of high and low expression. These findings suggest that, in addition to direct transcriptional autoregulation, ectopic *egr2b* expression in r2, r4, and r6 is promoted by positive feedback through downregulation of *cyp26b1* and *cyp26c1* and increased RA signaling.

*cyp26b1* and *cyp26c1* Contribute to Cell Identity Switching {#sec2.5}
-------------------------------------------------------------

The finding that low RA signaling antagonizes the maintenance of *egr2* expression in r2, r4, and r6 suggests a potential basis for cell identity switching. r3 or r5 cells that intermingle into even-numbered segments encounter territory with higher *cyp26b1* plus *cyp26c1* expression and thus lower RA levels, and this may contribute to downregulation of *egr2* expression. To test this, we analyzed the effect of knocking down *cyp26b1* and *cyp26c1*. We found that *cyp26b1* plus *cyp26c1* knockdown leads to an increased number of *egr2b*-expressing cells in r2, r4, and r6 ([Figures 6](#fig6){ref-type="fig"}A, 6B, and 6E), though with only a small increase in r6. This phenotype is also seen in embryos that are null mutants for *cyp26c1* ([Figure S3](#mmc1){ref-type="supplementary-material"}). As a further test, we increased the amount of cell intermingling between segments by carrying out analogous experiments with simultaneous knockdown of *ephA4*. We found that, when *cyp26b1* and *cyp26c1* knockdown is combined with the loss of *ephA4* function, there is a 4-fold increase in the number of ectopic *egr2b*-expressing cells in r2 and r4, but not in r6, compared with *cyp26b1* plus *cyp26c1* knockdown only ([Figures 6](#fig6){ref-type="fig"}C--6E). These findings support that identity switching of *egr2b*-expressing cells present in r2 or r4 requires RA signaling regulated by *cyp26b1* and *cyp26c1*.Figure 6*cyp26b1*, *cyp26c1*, and *hoxb1* Knockdown Increases Ectopic *egr2*-Expressing Cells(A--D) *egr2b* expression in 17 hpf embryos in which *cyp26b1* and *cyp26c1* were knocked down, compared with control morphants. Dorsal (A--D) and lateral (A′--D′) maximum intensity projections are shown. Knockdown of *cyp26b1* and *cyp26c1* causes an increased number of *egr2b*-expressing cells in r2, r4 and r6 (B and B′) compared with control embryos (A and A′); see also [Figure S3](#mmc1){ref-type="supplementary-material"}. Combined knockdown of *cyp26b1*, *cyp26c1*, and *ephA4* increases the number of *egr2b* expressing cells in r2 and r4 (D and D′) compared with *ephA4* morphant embryos (C and C′) and *cyp26b1* plus *cyp26c1* knockdown alone (B and B′).(E) Mean number of *egr2b*-expressing cells in even-numbered segments with 95% confidence intervals. Since blocking identity switching will favor segregation of cells that have initially intermingled, we counted *egr2*-expressing cells adjacent to r3 and r5 as well as isolated cells. Asterisks indicate statistical significance determined by Welsh\'s t test. For *cyp26b1* and *cyp26c1* morphants (n = 40) compared with control morphants (n = 22): r2, p \< 0.0001; r4, p \< 0.0001; r6, p = 0.038; all misplaced *egr2b*-expressing cells, p \< 0.0001. For *ephA4*, *cyp26b1*, and *cyp26c1* triple morphants (n = 21) compared with *ephA4* morphants (n = 33): r2, p \< 0.0001; r4, p = 0.01; r6, p = 0.31; total, p = 0.0001.(F--H) Knockdown of *hoxb1a* and *hoxb1b* (*hoxb1* MO) increases the number of *egr2b*-expressing cells in r4 (black arrowheads) at 18 hpf (G) compared with control embryos (F). *hoxb1* knockdown does not affect *cyp26b1* or *cyp26c1* expression ([Figure S4](#mmc1){ref-type="supplementary-material"}). (H) Mean number of ectopic *egr2b*-expressing cells with 95% confidence intervals. Asterisks indicate statistical significance determined by Welsh\'s t test: r2, p = 0.001; r4, p \< 0.0001; r6, p = 0.38. Control embryos, n = 6; *hoxb1* morphants, n = 26.(I--M) Knockdowns in the *egr2b:H2B-Citrine* line followed by detection of Citrine protein with anti-GFP antibody (green) and *egr2b* transcripts (red). The box in the bottom right of each panel is a magnified view of the *egr2b* transcript signal in the indicated area. Following knockdown of *ephA4* alone to increase cell intermingling, ectopic Citrine-expressing cells do not express detectable *egr2b* transcripts (I). *egr2b* transcripts are detected in ectopic Citrine-expressing cells when *ephA4* knockdown is combined with *hoxb1* (J and K) or *cyp26b1* plus *cyp26c1* knockdown (L and M). Empty arrowheads indicate Citrine-expressing cells lacking detectable *egr2b* transcripts, and filled arrowheads Citrine-expressing cells that express *egr2b* transcripts. Scale bars: 50 μm.

Our findings raise the question of how retinoid signaling affects *egr2* expression in even-numbered segments, since dissection of gene regulatory elements has not found a direct input of RA ([@bib4], [@bib10]). One potential explanation is that RA signaling in even-numbered segments promotes expression of a repressor of *egr2* gene expression. *hoxb1* is a good candidate to mediate such a mechanism in r4 since it is directly regulated by retinoid signaling ([@bib37], [@bib62], [@bib68]) and represses *egr2* expression ([@bib19], [@bib31], [@bib78]). We therefore carried out knockdown of *hoxb1a* and *hoxb1b*. We found that *hoxb1* knockdown does not alter *cyp26b1* or *cyp26c1* expression ([Figure S4](#mmc1){ref-type="supplementary-material"}) but leads to an increase in the number of isolated *egr2*-expressing cells in r4 ([Figures 6](#fig6){ref-type="fig"}F--6H).

Taken together, these findings suggest that *cyp26b1*, *cyp26c1*, and *hoxb1* mediate identity switching of r3 and r5 cells that have intermingled into adjacent segments. To directly test this, we carried out knockdowns in the *egr2:H2B-Citrine* line followed by detection of citrine protein and *egr2* transcripts. As shown previously ([Figure 2](#fig2){ref-type="fig"}), *egr2* transcripts are not detected in citrine-expressing cells that have intermingled into r4 following *ephA4* knockdown ([Figure 6](#fig6){ref-type="fig"}I). In contrast, *egr2* transcripts are detected in ectopic Citrine-expressing cells following knockdown of *hoxb1* ([Figures 6](#fig6){ref-type="fig"}J and 6K) or *cyp26b1* plus *cyp26c1* ([Figures 6](#fig6){ref-type="fig"}L and 6M).

Discussion {#sec3}
==========

Transplantation experiments in the hindbrain revealed plasticity in cell fate specification, which could enable homogeneous segmental identity to be maintained despite intermingling of cells across segment borders. To study whether cell intermingling and identity switching occurs during normal development in zebrafish, we created an early reporter of *egr2b* expression by insertion of *H2B-Citrine* into the *egr2b* gene locus. We find that cell identity switching occurs during hindbrain segmentation and show that this is regulated by coupling between segment identity and retinoid signaling. Our findings suggest a model in which r3 and r5 cells that intermingle into adjacent segments switch identity since they encounter cells with a higher expression level of *cyp26b1* and *cyp26c1* ([Figure 7](#fig7){ref-type="fig"}).Figure 7Model of *cyp26b1*, *cyp26c1*, and *hoxb1* in Cell Identity Switching(A) Segmental regulation of low *cyp26b1* and *cyp26c1* expression in r3 (magenta) and high expression in r4 (green) maintains high \[RA\] in r3 and low \[RA\] in r4.(B) In r3, *egr2* represses *cyp26b1* and *cyp26c1* expression, which in turn keeps RA levels high, repressing *hoxb1* expression. Egr2 also directly autoregulates its own expression and represses *hoxb1* expression. In r4, high *cyp26b1* and *cyp26c1* expression maintains a low level of RA, permitting expression of *hoxb1*. Hoxb1 autoregulates its own expression and represses expression of *egr2*.(C and E) When an r3 cell intermingles into r4, the surrounding cells have high *cyp26b1* and *cyp26c1* expression, which reduces the level of RA within the ectopic r3 cell. This promotes upregulation of *hoxb1* in the ectopic r3 cell, which represses *egr2* expression, causing the r3 cell to change identity to r4.(D and F) When an r3 cell intermingles into r4, but *cyp26b1* and *cyp26c1* are knocked down, the surrounding r4 cells no longer have high *cyp26b1/c1* expression, so RA levels remain high in the ectopic r3 cell. Consequently, *egr2* is not downregulated in the ectopic r3 cell (F).

Cell Intermingling and Identity Switching {#sec3.1}
-----------------------------------------

Cell lineage analysis in the chick hindbrain found that the clonal progeny of cells labeled before morphological boundaries are seen can contribute to adjacent segments, but when cells are labeled after boundary formation clones are confined to single segments ([@bib17]). These findings can be explained by the hierarchical relationships between genes that regulate segmental identity and cell segregation. The *egr2* gene specifies r3 and r5 identity ([@bib54], [@bib69]), which is coupled to A-P specification through reciprocal interactions with *hox* genes ([@bib57], [@bib68]), and is also a direct transcriptional regulator of *ephA4* ([@bib65]). Signaling between *ephA4* in r3/r5 and ephrins expressed in r2/r4/r6 underlies morphological boundary formation and the restriction of cell intermingling across borders ([@bib12], [@bib55], [@bib75]). It is therefore likely that intermingling between segments is largely confined to the period before EphA4 has been sufficiently upregulated to mediate cell segregation. In zebrafish, this period is also when convergent extension of the neural epithelium occurs, which through cell intercalation drives extensive intermingling along the A-P axis ([@bib28]). Based on these considerations, detection of intermingling between segments requires analysis with early reporters, and can explain why it was not observed in a study that used reporters expressed one step downstream of *egr2* ([@bib7]). This latter study used either an *egr2* autoregulatory element driving GFP or a Gal4 gene trap in *egr2b* that drives expression of UAS-mCherry, and reporter expression was first seen in r5 at 12.8 hpf, ∼2 hr after *egr2b* transcripts are detected. Since sharp borders have formed by this stage, it is likely that intermingling between segments has been restricted by the time that reporter expression is detected. The reporter line that we created enables direct detection of H2B-Citrine ∼1 hr after *egr2b* expression, and sensitivity was further increased by immunodetection of citrine protein.

We find isolated cells expressing H2B-Citrine reporter in even-numbered segments, which do not have a detectable level of *egr2b* transcripts, and express *hoxb1a* when present in r4. Thus, r3 and r5 cells that have intermingled into adjacent segments have switched identity to that of their new neighbors. One potential mechanism for switching is that, at the new location, cells respond to graded signals that specify A-P position. However, this does not account for the finding that groups of cells retain their original identity when transplanted to another segment ([@bib51], [@bib66]). The finding that forced mosaic expression of *egr2* in even-numbered segments can non-autonomously induce *egr2* expression ([@bib19]) suggests that this transcription factor regulates community signaling. We find that non-autonomous induction occurs when cells with forced *egr2* expression are intermingled with r2, r4, or r6 cells, but not when *egr2*-expressing and non-expressing cells are segregated. The induction of *egr2* expression in r2, r4, and r6 cells thus depends upon the number of *egr2*-expressing cells that they contact, suggesting that segmental identity is influenced by short-range interactions in which the majority wins.

Roles of *cyp26b1* and *cyp26c1* {#sec3.2}
--------------------------------

Previous studies have shown that the A-P specification of hindbrain segments is mediated by a posterior to anterior gradient of RA generated by Cyp26 enzymes. There is a distinct expression and regulation of different *cyp26* family members in the hindbrain. *cyp26a1* is expressed in an anterior to posterior gradient that forms at early stages and is directly regulated by RA and FGF signaling ([@bib73]). In contrast, *cyp26b1* and *cyp26c1* are not directly regulated by RA, and are expressed in dynamic segmental patterns ([@bib22], [@bib59]). Since *cyp26b1* and *cyp26c1* knockdown only has a strong effect on A-P patterning when combined with *cyp26a1* loss of function, these family members are thought to have parallel roles. Our findings provide evidence for a distinct role of *cyp26b1* and *cyp26c1*, in which they underlie identity switching of *egr2*-expressing cells that have intermingled into even-numbered segments.

We show that *egr2* underlies the lower level of *cyp26b1* and *cyp26c1* expression in r3 and r5 compared with r2, r4, and r6. Since Egr2 is a transcriptional activator, the repression of *cyp26b1* and *cyp26c1* expression may be indirect, but there is evidence that in some contexts Egr2 can act as a repressor ([@bib15], [@bib36], [@bib56]). It is currently not known how *cyp26b1* or *cyp26c1* expression is regulated in r2, r4, and r6. Although we find that *hoxb1* knockdown has no effect on *cyp26b1* or *cyp26c1* expression, it is possible that other *hox* genes are involved. The expression pattern of *cyp26b1* and *cyp26c1* suggests that, following initial patterning of the hindbrain by graded RA, a more complex pattern is formed with higher RA levels in odd- compared with even-numbered segments. The currently available transcriptional reporter lines are only sensitive enough to detect the high RA levels present in the spinal cord (reviewed by [@bib52]). Techniques for direct detection of RA have revealed a gradient in the hindbrain ([@bib58], [@bib60]), but, as the RA levels detected are noisy at the spatial resolution of hindbrain segments, it is unclear whether there is a continuously decreasing gradient or a more complex pattern.

A consequence of coupling *cyp26b1* and *cyp26c1* expression levels to segment identity ([Figures 7](#fig7){ref-type="fig"}A and 7B) is that, when r3 or r5 cells intermingle into adjacent segments, they will initially retain low expression of *cyp26b1* and *cyp26c1*, and are moving into territory with higher *cyp26b1/c1* expression. Previous work has shown that, in addition to a strong cell autonomous effect on RA levels, Cyp26 enzymes have a weak non-autonomous effect on adjacent cells, presumably by acting as a local sink for RA ([@bib49], [@bib50], [@bib73]). This predicts that, when single cells intermingle into an adjacent segment, the amount of RA they experience can be influenced by the level of Cyp26 enzymes in their neighbors. We find that knockdown of *cyp26b1* plus *cyp26c1* leads to an increase in the number of ectopic *egr2*-expressing cells in r2 and r4, although not in r6. Furthermore, there is a greater number of ectopic *egr2*-expressing cells when intermingling is increased by simultaneous loss of ephA4 function. Thus, *cyp26b1* and *cyp26c1* enable the identity switching of r3 and r5 cells that have intermingled into adjacent segments. The reason why they are required in r2 and r4, but not r6, is unclear, but may relate to the anterior to posterior progression of *cyp26b1* and *cyp26c1* expression, which is upregulated in r2--r4 at 10 hpf, and in r6 at 11 hpf ([@bib20], [@bib22]). This suggests that another mechanism acts to mediate identity switching in r6 during early stages when intermingling between segments occurs.

Further evidence for how *egr2b* is regulated when expressed in r2, r4, or r6 came from use of a heat shock inducible line to induce transient *egr2b* expression, which due to autoregulation is then maintained throughout the hindbrain. Since ectopic *egr2b* expression downregulates *cyp26b1* and *cyp26c1* expression in r2, r4, and r6, this is predicted to increase RA signaling to a similar level as occurs in r3 and r5. We find that inhibition of RAR function disrupts the maintenance of *egr2b* expression in even-numbered segments, leading to a heterogeneous mixture of expressing and non-expressing cells. Taken together, these findings reveal that low RA signaling (high *cyp26b1*/*c1* or inhibition of RAR) promotes downregulation of *egr2b* expression in even-numbered segments, and that high RA (knockdown of *cyp26b1/c1*, or overexpression of *egr2*, which represses *cyp26b1* and *cyp26c1*) enables maintenance of *egr2* expression. We therefore propose that an *egr2*-expressing cell that intermingles into an adjacent segments is surrounded by cells with a higher level of *cyp26b1/c1*, which non-autonomously decreases RA levels in the *egr2*-expressing cell and leads to identity switching ([Figure 7](#fig7){ref-type="fig"}C). In contrast, such identity switching does not occur when an *egr2*-expressing cell intermingles into territory in which *cyp26b1/c1* levels have been lowered by gene knockdown ([Figure 7](#fig7){ref-type="fig"}D).

Relationship between RA Signaling and *egr2* Expression {#sec3.3}
-------------------------------------------------------

Since dissection of gene regulatory elements has not found any direct input of RA into regulation of *egr2* ([@bib4], [@bib10]), our findings raise the question of how changes to RA levels affect *egr2* gene expression in even-numbered segments. We tested a role of *hoxb1*, since it represses *egr2* expression ([@bib19], [@bib31], [@bib78]) and is directly upregulated in r4 and repressed in r3 and r5 by retinoid signaling ([@bib34], [@bib37], [@bib62], [@bib68]). Consistent with previous studies ([@bib31], [@bib80]), we find that knockdown of *hoxb1* genes leads to an increase in the number of *egr2*-expressing cells in r4. We therefore propose that lower RA levels maintained by *cyp26b1* and *cyp26c1* in r4 enable upregulation of *hoxb1* expression in r3 and r5 cells that have intermingled, which in turn represses *egr2b* expression ([Figures 7](#fig7){ref-type="fig"}C and 7E). Following knockdown of *cyp26b1* and *cyp26c1*, there is a higher level of RA in r4, which does not promote upregulation of *hoxb1*, and consequently *egr2b* expression is maintained ([Figures 7](#fig7){ref-type="fig"}D and 7F).

Distinct Regulation of *egr2* at Normal and Ectopic Locations {#sec3.4}
-------------------------------------------------------------

Whereas single ectopic cells downregulate *egr2*, we find that isolated cells can express *egr2* when present at the normal A-P position of r3. This suggests that A-P regulation of *egr2* expression is dominant over the proposed community signaling. Similarly, inhibition of RAR at late stages leads to downregulation of ectopic *egr2* expression in r2, r4, and r6 but does not disrupt *egr2* expression in r3 and r5. These findings are consistent with the mechanisms that regulate *egr2* gene expression. Due to the combinatorial input of Fgf signaling and Hox and Nlz transcription factors, an initiator element that regulates *egr2* expression is strongly activated in r3 but has weak activity in r2 and r4 ([@bib31]). This generates sufficient Egr2 protein in r3 to maintain and amplify subsequent expression through an autoregulatory element ([@bib4], [@bib10]). Our findings suggest that strong activation of the initiator element plus autoregulation is able to maintain *egr2* gene expression even in single r3 cells flanked by r2 and r4 cells, which can have non-autonomous effects on RA levels. In contrast, r3 or r5 cells that intermingle into adjacent segments are in territory with low activation of the initiator element, and thus the non-autonomous effects of *cyp26b1* and *cyp26c1* are able to antagonize the maintenance of *egr2* expression.

Community Regulation of Cell Identity {#sec3.5}
-------------------------------------

In classical models of community effects, a transcription factor that specifies cell identity upregulates expression of a signaling molecule that can induce expression of the transcription factor in neighboring cells ([@bib3], [@bib6], [@bib61]). Our findings provide evidence for a related mechanism, in which coupling between segment identity and the expression level of retinoid degrading enzymes sets the amount of RA signaling in a group of cells. The coupling of *cyp26b1* and *cyp26c1* expression to segment identity can account for the finding that groups of cells maintain their original identity when transplanted to another segment ([@bib51], [@bib66]). Consistent with this, mosaic overexpression of *cyp26c1* induced ectopic *hoxb1* gene expression when present in groups of cells but not in single cells ([@bib34]). Interestingly, r3 and r5 gene expression occurred in groups of cells in adjacent segments following overexpression of truncated EphA4 ([@bib75]), which is predicted to greatly increase cell intermingling by both blocking Eph receptor activation and activating ephrin reverse signaling. The extent of intermingling that occurs during normal development, or even single Eph receptor knockdown, leads to isolated ectopic cells that come under the influence of the level of *cyp26b1/c1* expression and RA degradation in neighboring cells. In this mechanism, cell identity regulation depends upon how many neighbors are of the same or different type, and thus switching does not occur at borders of segregated cell populations. This may provide a more reliable mechanism for switching than responding to an RA gradient, which is not able to specify identity along the A-P axis with single-cell precision ([@bib78]).

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Anti-Digoxigenin-AP (*in situ*)RocheCat\# 11093274910; RRID: [AB_514497](nif-antibody:AB_514497){#intref0010}Anti-Fluorescein-AP (*in situ*)RocheCat\# 11426338910; RRID: [AB_514504](nif-antibody:AB_514504){#intref0015}Anti-GFP (IF)Torrey Pines BiolabsCat\# TP401 071519; RRID: [AB_10013661](nif-antibody:AB_10013661){#intref0020}Anti-Myc (IF)Santa Cruz BiotechnologyCat\# sc-40; RRID: [AB_627268](nif-antibody:AB_627268){#intref0025}Anti-Rabbit Alexa Fluor 488 (IF)Thermo Fisher ScientificCat\# R37116; RRID: [AB_2556544](nif-antibody:AB_2556544){#intref0030}Anti-Mouse Alexa Fluor 488 (IF)Thermo Fisher ScientificCat\# R37120; RRID: [AB_2556548](nif-antibody:AB_2556548){#intref0035}**Chemicals, Peptides, and Recombinant Proteins**BCIPRocheCat\# 11383221001NBTRocheCat\# 11383213001AGN193109Santa Cruz BiotechnologyCat\# sc-210768Fast Blue BBSigmaCat\# F3378NAMP (Naphthol AS-MX phosphate)SigmaCat\# N5000Fast Red TR/Naphthol AS-MX TabletsSigmaCat\# F4648Cas9 NLSNew England BiolabsCat\# M0646M**Experimental Models: Organisms/Strains**Zebrafish *Danio rerio*: WTN/AN/AZebrafish *Danio rerio*: Tg \[egr2b:H2B-Citrine\]This studyN/AZebrafish *Danio rerio*: Tg \[CNE1:egr2b-Myc\]This studyN/AZebrafish *Danio rerio*: Tg \[HS:egr2b-Myc\]This studyN/A**Oligonucleotides**See supplementary tableThis studyN/A**Recombinant DNA**pCS2b1a: probe synthesis hoxb1a: linearize KpnI: polymerase T3[@bib38]N/ApBS-hoxa2: probe synthesis hoxa2: linearize KpnI: polymerase T3[@bib47]N/ApCS2-cyp26b1: probe synthesis cyp26b1: linearize BglII: polymerase Sp6[@bib22]N/ApCS2-cyp26c1: probe synthesis cyp26c1: linearize SmaI: polymerase T7[@bib22]N/ApBS-krox-20: full-length probe synthesis egr2b: linearize PstI: polymerase: T3[@bib43]N/ApBS-krox-20: 3′ UTR probe synthesis egr2b: linearize SphI: polymerase: T3[@bib43]N/ApT3Ts-Tol2: mRNA synthesis Tol2: linearize SpeI: polymerase T3[@bib1]N/ApDONR221Thermo Fisher ScientificCat\# 12536017p5E-hsp70l[@bib30]N/Ap3E-MTpA[@bib30]N/ApDestTol2pACryGFP[@bib2]N/ApCS2-H2B-citrine: probe synthesis citrine: linearize XmaI: polymerase T3[@bib40]N/ApCS2-H2B-EGFP: mRNA synthesis H2B-eGFP: linearize NotI: polymerase Sp6[@bib40]N/ApMiniTol2-Pax3CNE1-TKprom-Gal4-UAS:H2Bcitrine[@bib41]N/ApDR274: linearize BsaI-HF[@bib23]N/AMLM3613: mRNA synthesis cas9: linearize PmeI: polymerase T7[@bib23]N/A**Software and Algorithms**FIJI (ImageJ)[@bib53]N/AFluorenderN/AN/A

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, David G. Wilkinson (<david.wilkinson@crick.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Maintenance of Zebrafish Strains {#sec4.3.1}

Wild type and transgenic zebrafish embryos were obtained by natural spawning and raised at 28.5°C as described ([@bib72]). Embryos were staged by hours post-fertilization (hpf) at 28.5°C and/or morphological features ([@bib27]). The zebrafish work was carried out under a UK Home Office Licence under the Animals (Scientific Procedures) Act 1986 and underwent full ethical review.

Method Details {#sec4.4}
--------------

### Constructs and Transgenesis {#sec4.4.1}

pMiniTol2-Pax3CNE1-TKprom-Gal4-UAS:Egr2b-Myc (referred to as CNE1:egr2b-Myc) was created by replacing the H2B-citrine coding sequence from pMiniTol2-Pax3CNE1-TKprom-Gal4-UAS:H2B-citrine ([@bib41]) with the *egr2b* coding sequence and C-terminal Myc tag, amplified from hsp70:Egr2b-Myc-ACG. For transient transgenesis, 15-18 pg DNA and 36 pg Tol2 transposase RNA were injected into one-cell stage embryos.

The HS:egr2b-Myc;αCrystallin-GFP expression vector was generated using plasmids from the Tol2Kit ([@bib30]) and pDestTol2pACryGFP destination vector (Addgene plasmid \#64022) ([@bib2]). The *egr2b* middle entry vector (pME-*egr2b*) was created by BP recombination between the pDONR-221 vector and the *egr2b* coding sequence ([@bib43]) flanked by attB sites. The mBait-H2B-Citrine donor plasmid was generated by insertion of a cFos minimal promoter, mBait gRNA target site, H2B-Citrine coding sequence and SV40 polyadenylation signal into a pBluescript II KS backbone.

The Tg\[egr2b:H2B-Citrine\] line (fci3) was generated by CRISPR/Cas9-mediated insertion using the strategy described in ([@bib29]). Embryos were injected at the one cell stage with Cas9 mRNA (350 pg), mBait gRNA (50 pg), gRNA (100 pg) targeting a sequence 893 bp upstream of the transcriptional start site of Egr2b (ATTCTGAGCTATCCAGTACGG), and mBait-H2B-Citrine donor plasmid (10-20 pg). CRISPR/Cas9-mediated mutation of the ephA4 and cyp26c1 genes was carried out using the gRNAs described in [Table S1](#mmc1){ref-type="supplementary-material"}. The hs-egr2b line (fci4) was generated by injection of an Hsp70:Egr2b-Myc;αCrystallin-GFP expression vector.

### Morpholino Injection {#sec4.4.2}

Morpholino oligonucleotides (MOs) were obtained from GeneTools (Oregon, USA) and were aliquoted and stored at room temperature in glass vials. MOs were injected into the yolk of blastomeres at the 1-4 cell stage in combination with a p53 translation-blocking MO to block off--target effects mediated by activation of apoptotic pathways ([@bib18], [@bib48]). 4 ng MO was injected, except for ephA4 MO for which 5 ng was used. The MOs used are as follows: egr2b translation-blocking MO (AGTTTTAGCTGTCATCGTGAAGTCC); egr2a translation-blocking MO (CATGTGCTCCATGTTGGGAAGATTT); ephA4 ([@bib12]); cyp26b1 and cyp26c1 ([@bib22]); hoxb1a and hoxb1b ([@bib39]); p53 ([@bib32]). Control morphant embryos were injected with a corresponding amount of the standard control MO (GeneTools). egr2a and egr2b MO block egr2b autoregulation and cause loss of r3 and r5 as occurs in an egr2b zebrafish mutant ([@bib4]) and egr2 mouse mutant ([@bib54], [@bib69]). All other MOs used have previously been characterized and their efficacy and specificity demonstrated as follows. ephA4 MO blocks generation of EphA4 protein and disrupts the sharpening of the r2/r3, r3/r4 and r5/r6 borders ([@bib12], [@bib64]); we show that the same phenotype occurs in an ephA4 mutant (fci2) which has a 4 bp deletion at residue 158 in the ligand-binding domain ([Figure S1](#mmc1){ref-type="supplementary-material"}). cyp26b1 MO and cyp26c1 MO cause posteriorisation of the hindbrain when combined with a cyp26a1 mutant, and this is phenocopied by chemical blocking of Cyp26 enzymes ([@bib22]). We show that the phenotype of ectopic egr2-expressing cells seen in morphants also occurs in cyp26c1 mutant embryos ([Figure S3](#mmc1){ref-type="supplementary-material"}). hoxb1a MO disrupts hoxb1a autoregulation, and hoxb1b MO causes a decreased size of r4 and increase in r3 ([@bib39]); the same phenotypes but more severe are seen in hoxb1a and hoxb1b mutants ([@bib71], [@bib80]). p53 MO blocks activation of apoptotic pathways, as also occurs in p53 mutant zebrafish ([@bib18], [@bib32], [@bib48]).

### Pharmacological and Heat Shock Treatments {#sec4.4.3}

To block RA signaling, dechorionated embryos were treated with 10 μM AGN193109 in 2% DMSO in 0.65x Danieau's solution; control embryos were treated with 2% DMSO in 0.65x Danieau's solution. For induction of heat shock regulated constructs, embryos were placed at 36°C for 30 min in pre-warmed 0.65 x Danieau\'s solution at the stages indicated.

### Cell Transplantation {#sec4.4.4}

Donor embryos were injected at the 1 cell stage with 100 pg H2B-eGFP RNA. Cell transplantation was performed at 4 hpf, with donor cells targeted to the future hindbrain based on fate maps ([@bib26]).

### *In Situ* Hybridization and Immunocytochemistry {#sec4.4.5}

Embryos of the desired stage were fixed in 4% paraformaldehyde/PBS for 3 h at room temperature or overnight at 4°C. Fixed embryos were stored in 100% methanol at −20°C prior to processing by *in situ* hybridization or immunocytochemistry. Probes used for *in situ* hybridization have been previously described: egr2b ([@bib43]); citrine ([@bib40]); hoxb1a ([@bib38]); cyp26b1 ([@bib79]); cyp26c1 (formerly known as cyp26d1) ([@bib20]). Antisense riboprobes were labeled with digoxigenin-UTP or fluorescein-UTP. *In situ* hybridization and color development with BCIP/NBT or Fast Blue was conducted as previously described ([@bib33], [@bib76]). Two color fluorescent *in situ* hybridization was carried out using Fast Blue and Fast Red substrates. After BCIP/NBT color development, embryos were re-fixed, cleared in 70% glycerol/PBS, and mounted for imaging using a Zeiss Axioplan2 with Axiocam HRc camera. In some experiments ([Figures 6](#fig6){ref-type="fig"}I--6M), egr2b transcripts were detected by hybridization chain reaction (HCR) using the protocol detailed in ([@bib9]). A kit containing a DNA probe set, a DNA HCR amplifier, and hybridization, wash and amplification buffers was purchased from Molecular Instruments ([molecularinstruments.org](http://molecularinstruments.org){#intref0045}). The egr2b probes initiate B5 (Alexa594) amplifier.

For immunocytochemistry, embryos were fixed for 2 h at room temperature in 4% paraformaldehyde, washed in PBT, then dechorionated and blocked for 1 h in 5% goat serum in PBT. Primary antibodies were used at the following concentrations in 2.5% goat serum: rabbit anti-GFP (1:500; 1:400 after *in situ* hybridization); Myc (1:400 after *in situ* hybridization). Secondary antibodies were used at the following concentrations: goat anti-rabbit Alexa Fluor® 488 (IgG H + L) (1:500 dilution); goat anti-mouse Alexa Fluor® 488 (IgG H + L) (1:500 dilution). Embryos were incubated in DAPI to stain nuclei. Embryos were then cleared in 70% glycerol/PBS, and mounted for imaging on a Leica TCS SP2 confocal microscope or Zeiss LSM700 confocal microscope.

### Live Imaging and Analysis {#sec4.4.6}

Dechorionated embryos were embedded in 0.6% low melting agarose (Sigma)/0.5x Danieau\'s solution within a 1% agarose (Bio-Rad Laboratories Inc.)/0.5x Danieau\'s solution-coated chambered coverslip with individual embryo-shaped wells filled with 0.5x Danieau\'s solution. Embryos were imaged using an inverted Zeiss LSM710 confocal microscope with 20x lens, NA 0.8. Z-stacks with a slice depth of 2 μm were acquired every 3 minutes. ImageJ (NIH) was used for image processing. The Correct 3D Drift ImageJ plug-in ([@bib45]) was used to correct for 3D drift in time lapse movies. FluoRender v. 2.20.0 (University of Utah) was used to create 3D projections.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Quantification of Ectopic Cells {#sec4.5.1}

The number of cells in r2, r4 and r6 that express egr2b transcripts and/or H2B-citrine reporter was manually counted from confocal stacks. Statistical significance was determined using Welsh\'s T test in GraphPad Prism 7 as indicated in the Figure legends.
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